Evolving Treatment Options for the Treatment of HCC with Immunotherapy and LDT


Activity Info

This activity addresses ongoing research on emerging immunotherapy agents and clinical trial data on the use of these agents in combination, succession, and sequentially with interventional liver directed therapy (LDT).

CME Information is available in the activity.


Webinar | Oncology | CME (AMA PRA Category 1 Credit) | 1.0 - 60 mins | Hepatology | Internal Medicine | Radiology | Nurse | Nurse Practitioner | Online | ANCC | Hepatocellular Carcinoma (HCC) | 

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA